DOAC dosing in older patients with nonvalvular atrial fibrillationAn oral anticoagulant is recommended for most patients aged ≥ 65 years with nonvalvular atrial fibrillation (NVAF), to reduce the risk of stroke. It’s time to take off our business blindersEarly in my career, I went about my work somewhat blindered, focused on my specific role. Retiring, island-style Dr. Geoff Heseltine, was an ER doctor in Senneville, Que., when he decided at age 60, it was time to make a change. Editorial: The Money Issue The case for national licences (and how Australia did it). Fixing the national licence crisis New CMA president wants a national ‘conversation’ about pan-Canadian licensure. Building strategic networks Pharmacists want novel and collaborative opportunities. The reality is, they are largely hustling inside the four walls of their pharmacies. Improving pharmacy care in rural communities Pearls you can use in your practice now! Tofacitinib: cardiovascular and cancer risks Janus kinase inhibitors are oral targeted agents used for the treatment of various chronic inflammatory diseases including rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and atopic dermatitis. Rx for medicine and parenthood Being both a doctor and a parent is not for the faint of heart. Preparation and managing expectations are key. Attention to details: An update on ADHD treatment First Previous 54 55 56 57 58 Next Last
